Efficacy and safety of crizotinib in advanced alk-positive non-small cell lung cancer (NSCLC) results from a phase II global trial Meeting Abstract


Authors: Ferreira, C. G.; Barrios, C.; Shaw, A. T.; Shi, Y. K.; De Pas, T. M.; Yang, P. C.; Riely, G. J.; Crino, L.; Iyer, S.; Polli, A.; Lanzalone, S.; Kim, D. W.
Abstract Title: Efficacy and safety of crizotinib in advanced alk-positive non-small cell lung cancer (NSCLC) results from a phase II global trial
Meeting Title: 5th Latin American Conference on Lung Cancer (LALCA)
Journal Title: Journal of Thoracic Oncology
Volume: 7
Issue: 7
Meeting Dates: 2012 Jul 25-27
Meeting Location: Rio De Janeiro, Brazil
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2012-10-01
Start Page: S107
End Page: S108
Language: English
ACCESSION: WOS:000306458700012
PROVIDER: wos
DOI: 10.1097/JTO.0b013e318262df76
Notes: --- - Meeting Abstract: MO.06 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely